TrialThe Lancet. Infectious diseases2025

Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trial.

Laina D Mercer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.